ValSource Senior Consultant Christopher M. Hanff Joins PDA Letter Editorial Committee
December 14, 2015
ValSource announced Senior Consultant Christopher M. Hanff has been accepted as a member of the PDA Letter Editorial Committee (“PLEC”) for 2016-2017. The PDA Letter is the Parenteral Drug Administration’s (“PDA”) membership magazine covering the science, technology and regulation behind the manufacturing of sterile injectables. The PLEC provides editorial oversight for all feature articles supplied by PDA members, industry and regulatory experts and PDA staff.
Mr. Hanff has over 16 years of experience in biopharmaceutical operations and quality systems. He has worked on a number of projects ranging from suite start-ups, design-construction and commercialization efforts, to pharmaceutical manufacturing management. He has extensive experience in essential quality management systems oversight, design, and remediation, including under FDA sanctioned consent decree. Most recently, he has been involved in the development and implementation of innovative approaches to product transport and shipping validation.
The Parenteral Drug Association is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community, with over 10,500 members worldwide.